Guardian Pharmacy Service (NYSE:GRDN) reported quarterly losses of $(2.00) per share which missed the analyst consensus estimate of $0.21 by 1052.38 percent. The company reported quarterly sales of $314.39 million which beat the analyst consensus estimate of $303.16 million by 3.71 percent. This is a 19.66 percent increase over sales of $262.74 million the same period last year.